IMPAX To Present at Upcoming Investment Conferences

March 11, 2008

HAYWARD, Calif.--(BUSINESS WIRE)--March 11, 2008--IMPAX Laboratories, Inc. (OTC:IPXL) today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will present at two upcoming investment conferences:

  • IMPAX will present at the Cowen and Company 28th Annual Health Care Conference on Monday, March 17th, at 2:30 p.m. Eastern Time. The conference will be held at the Boston Marriott Copley Place from March 17 to 20.
  • The Company will also present at the Lehman Brothers Eleventh Annual Global Healthcare Conference on Tuesday, March 18th, at 5:15 p.m. Eastern Time. The conference will be held at the Loews Miami Beach Hotel from March 18 to 20.

Individuals may listen to the live or archived presentations made at the conferences, which will be posted in the investor relations section of the Company's web site at To listen to the live presentations, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software. These presentations will be archived on the Company's web site for 90 days.

About IMPAX Laboratories, Inc.

IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and markets its branded products through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at:

CONTACT: Company Contacts:
IMPAX Laboratories, Inc.
Larry Hsu, Ph.D. President & CEO
510-476-2000, Ext. 1111
Arthur A. Koch, Jr., Sr. VP & CFO
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
Bruce Voss, 310-691-7100

SOURCE: IMPAX Laboratories, Inc.